GlassScriptPhysician profile
Ashley Mahaffey
NPI 1346825593
$2,779.21
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $382 · 2022: $1,279 · 2023: $524 · 2024: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725 · Travel and Lodging: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.26 |
| Travel and Lodging | $392.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $590.61 | 2021-2024 | Fasenra |
| Intuitive Surgical, INC. | $392.89 | 2023 | Da Vinci Surgical System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $322.45 | 2021-2024 | |
| Glaxosmithkline, LLC. | $289.58 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $188.84 | 2021-2022 | |
| Pulmonx Corporation | $174.34 | 2022-2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Mylan Specialty L.P. | $170.58 | 2022 | |
| United Therapeutics Corporation | $135.90 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $121.81 | 2024 | Dupixent |
| Teva Pharmaceuticals USA, INC. | $80.06 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.01 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.80 | 2022 | |
| Baxter Healthcare | $43.18 | 2022 | |
| Gilead Sciences, INC. | $33.07 | 2022 | |
| Electromed, INC. | $21.78 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $20.48 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $18.68 | 2022 | |
| Ani Pharmaceuticals, INC. | $17.62 | 2022 | |
| Genentech USA, INC. | $16.89 | 2022 | |
| Philips North America LLC | $14.05 | 2022 | |
| Advanced Respiratory, INC | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Mahaffey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.